1	Investigating	Investigate	B-VP	VBG	O	0	ROOT	0
2	the	the	B-NP	DT	O	3	NMOD	0
3	causes	cause	I-NP	NNS	O	1	OBJ	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	low	low	B-NP	JJ	O	7	NMOD	0
6	birth	birth	I-NP	NN	O	7	NMOD	0
7	weight	weight	I-NP	NN	O	4	PMOD	0
8	in	in	B-PP	IN	O	1	VMOD	0
9	contrasting	contrast	B-VP	VBG	O	8	PMOD	0
10	ovine	ovine	B-NP	JJ	O	11	NMOD	0
11	paradigms	paradigm	I-NP	NNS	O	9	OBJ	0
12	.	.	O	.	O	1	P	0

1	Intrauterine	Intrauterine	B-NP	JJ	O	3	NMOD	0
2	growth	growth	I-NP	NN	O	3	NMOD	0
3	restriction	restriction	I-NP	NN	O	8	SUB	0
4	(	(	O	(	O	6	DEP	0
5	IUGR	IUGR	B-NP	NN	B-protein	6	DEP	0
6	)	)	O	)	O	3	NMOD	0
7	still	still	B-ADVP	RB	O	8	VMOD	0
8	accounts	account	B-VP	VBZ	O	0	ROOT	0
9	for	for	B-PP	IN	O	8	VMOD	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	large	large	I-NP	JJ	O	12	NMOD	0
12	incidence	incidence	I-NP	NN	O	9	PMOD	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	infant	infant	B-NP	NN	O	15	NMOD	0
15	mortality	mortality	I-NP	NN	O	17	NMOD	0
16	and	and	I-NP	CC	O	17	NMOD	0
17	morbidity	morbidity	I-NP	NN	O	13	PMOD	0
18	worldwide	worldwide	B-ADVP	RB	O	17	NMOD	0
19	.	.	O	.	O	8	P	0

1	Many	Many	B-NP	JJ	O	12	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	7	NMOD	0
4	circulatory	circulatory	I-NP	JJ	O	7	NMOD	0
5	and	and	I-NP	CC	O	7	NMOD	0
6	transport	transport	I-NP	NN	O	7	NMOD	0
7	properties	property	I-NP	NNS	O	2	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	11	NMOD	0
10	sheep	sheep	I-NP	NN	O	11	NMOD	0
11	placenta	placenta	I-NP	NN	O	8	PMOD	0
12	are	be	B-VP	VBP	O	27	VMOD	0
13	similar	similar	B-ADJP	JJ	O	12	PRD	0
14	to	to	B-PP	TO	O	13	AMOD	0
15	those	those	B-NP	DT	O	14	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	the	the	B-NP	DT	O	19	NMOD	0
18	human	human	I-NP	JJ	O	19	NMOD	0
19	placenta	placenta	I-NP	NN	O	16	PMOD	0
20	and	and	B-PP	CC	O	12	VMOD	0
21	as	as	B-PP	IN	O	12	VMOD	0
22	such	such	B-NP	JJ	O	21	PMOD	0
23	,	,	O	,	O	12	P	0
24	the	the	B-NP	DT	O	26	NMOD	0
25	pregnant	pregnant	I-NP	JJ	O	26	NMOD	0
26	sheep	sheep	I-NP	NN	O	27	SUB	0
27	offers	offer	B-VP	VBZ	O	0	ROOT	0
28	an	an	B-NP	DT	O	30	NMOD	0
29	excellent	excellent	I-NP	JJ	O	30	NMOD	0
30	model	model	I-NP	NN	O	27	OBJ	0
31	in	in	B-PP	IN	O	30	NMOD	0
32	which	which	B-NP	WDT	O	31	PMOD	0
33	to	to	B-VP	TO	O	34	VMOD	0
34	study	study	I-VP	VB	O	31	SBAR	0
35	the	the	B-NP	DT	O	36	NMOD	0
36	development	development	I-NP	NN	O	34	OBJ	0
37	of	of	B-PP	IN	O	36	NMOD	0
38	IUGR	IUGR	B-NP	NN	B-protein	37	PMOD	0
39	.	.	O	.	O	27	P	0

1	Two	Two	B-NP	CD	O	3	NMOD	0
2	natural	natural	I-NP	JJ	O	3	NMOD	0
3	models	model	I-NP	NNS	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	ovine	ovine	B-NP	JJ	O	6	NMOD	0
6	IUGR	IUGR	I-NP	NN	B-protein	4	PMOD	0
7	are	be	B-VP	VBP	O	0	ROOT	0
8	those	those	B-NP	DT	O	17	NMOD	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	hyperthermic	hyperthermic	B-NP	JJ	O	11	NMOD	0
11	exposure	exposure	I-NP	NN	O	9	PMOD	0
12	during	during	B-PP	IN	O	11	NMOD	0
13	pregnancy	pregnancy	B-NP	NN	O	12	PMOD	0
14	,	,	O	,	O	17	P	0
15	and	and	O	CC	O	17	NMOD	0
16	adolescent	adolescent	B-NP	JJ	O	17	NMOD	0
17	overfeeding	overfeeding	I-NP	NN	O	7	PRD	0
18	,	,	O	,	O	17	P	0
19	also	also	B-ADVP	RB	O	17	NMOD	0
20	during	during	B-PP	IN	O	17	NMOD	0
21	pregnancy	pregnancy	B-NP	NN	O	20	PMOD	0
22	.	.	O	.	O	7	P	0

1	Both	Both	B-NP	DT	O	2	NMOD	0
2	models	model	I-NP	NNS	O	3	SUB	0
3	yield	yield	B-VP	VBP	O	0	ROOT	0
4	significantly	significantly	B-NP	RB	O	5	AMOD	0
5	reduced	reduce	I-NP	VBN	O	7	NMOD	18	reduced
6	placental	placental	I-NP	JJ	O	7	NMOD	0
7	weights	weight	I-NP	NNS	O	12	NMOD	0
8	and	and	O	CC	O	12	NMOD	0
9	an	an	B-NP	DT	O	12	NMOD	0
10	asymmetrically	asymmetrically	I-NP	RB	O	11	AMOD	0
11	growth-restricted	growth-restricted	I-NP	JJ	O	12	NMOD	18	restricted
12	fetus	fetus	I-NP	NN	O	3	OBJ	0
13	,	,	O	,	O	3	P	0
14	and	and	O	CC	O	3	VMOD	0
15	display	display	B-VP	VBP	O	3	VMOD	0
16	altered	alter	I-VP	VBN	O	19	NMOD	0
17	maternal	maternal	B-NP	JJ	O	19	NMOD	0
18	hormone	hormone	I-NP	NN	O	19	NMOD	0
19	concentrations	concentration	I-NP	NNS	O	15	OBJ	0
20	,	,	O	,	O	19	P	0
21	indicative	indicative	B-ADJP	JJ	O	19	NMOD	0
22	of	of	B-PP	IN	O	21	AMOD	0
23	an	an	B-NP	DT	O	26	NMOD	0
24	impaired	impaired	I-NP	JJ	O	26	NMOD	18	impaired
25	trophoblast	trophoblast	I-NP	NN	O	26	NMOD	0
26	capacity	capacity	I-NP	NN	O	22	PMOD	0
27	.	.	O	.	O	3	P	0

1	Additionally	Additionally	B-ADVP	RB	O	10	VMOD	0
2	,	,	O	,	O	10	P	0
3	impaired	impaired	B-NP	JJ	O	5	NMOD	18	impaired
4	placental	placental	I-NP	JJ	O	5	NMOD	0
5	angiogenesis	angiogenesis	I-NP	NN	O	9	NMOD	3	angiogenesis
6	and	and	O	CC	O	9	NMOD	0
7	uteroplacental	uteroplacental	B-NP	JJ	O	9	NMOD	0
8	blood	blood	I-NP	NN	O	9	NMOD	0
9	flow	flow	I-NP	NN	O	10	SUB	0
10	appears	appear	B-VP	VBZ	O	0	ROOT	0
11	to	to	I-VP	TO	O	12	VMOD	0
12	be	be	I-VP	VB	O	10	VMOD	0
13	an	an	B-NP	DT	O	15	NMOD	0
14	early	early	I-NP	JJ	O	15	NMOD	0
15	defect	defect	I-NP	NN	O	12	PRD	0
16	in	in	B-PP	IN	O	15	NMOD	0
17	both	both	B-NP	CC	O	22	NMOD	0
18	the	the	I-NP	DT	O	22	NMOD	0
19	hyperthermic	hyperthermic	I-NP	JJ	O	22	NMOD	0
20	and	and	I-NP	CC	O	22	NMOD	0
21	adolescent	adolescent	I-NP	JJ	O	22	NMOD	0
22	paradigms	paradigm	I-NP	NNS	O	16	PMOD	0
23	.	.	O	.	O	10	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	effects	effect	I-NP	NNS	O	10	SUB	16	effects
3	of	of	B-PP	IN	O	2	NMOD	0
4	these	these	B-NP	DT	O	5	NMOD	0
5	alterations	alteration	I-NP	NNS	O	3	PMOD	16	alterations
6	in	in	B-PP	IN	O	2	NMOD	0
7	placental	placental	B-NP	JJ	O	9	NMOD	0
8	functional	functional	I-NP	JJ	O	9	NMOD	0
9	development	development	I-NP	NN	O	6	PMOD	2	development
10	appear	appear	B-VP	VBP	O	0	ROOT	0
11	to	to	I-VP	TO	O	12	VMOD	0
12	be	be	I-VP	VB	O	10	VMOD	0
13	irreversible	irreversible	B-ADJP	JJ	O	12	PRD	0
14	.	.	O	.	O	10	P	0

1	IUGR	IUGR	B-NP	NN	O	2	NMOD	0
2	fetuses	fetus	I-NP	NNS	O	3	SUB	0
3	are	be	B-VP	VBP	O	0	ROOT	0
4	both	both	B-ADJP	DT	O	7	AMOD	0
5	hypoxic	hypoxic	I-ADJP	JJ	O	7	AMOD	0
6	and	and	I-ADJP	CC	O	7	AMOD	0
7	hypoglycaemic	hypoglycaemic	I-ADJP	JJ	O	3	PRD	0
8	,	,	O	,	O	3	P	0
9	and	and	O	CC	O	3	VMOD	0
10	have	have	B-VP	VBP	O	3	VMOD	0
11	reduced	reduce	I-VP	VBN	O	10	VC	18	reduced
12	insulin	insulin	B-NP	NN	B-protein	16	NMOD	0
13	and	and	O	CC	O	16	NMOD	0
14	insulin-like	insulin-like	B-NP	JJ	B-protein	16	NMOD	0
15	growth	growth	I-NP	NN	I-protein	16	NMOD	0
16	factor-1	factor-1	I-NP	NN	I-protein	23	NMOD	0
17	(	(	O	(	O	19	DEP	0
18	IGF-1	IGF-1	B-NP	NN	B-protein	19	DEP	0
19	)	)	O	)	O	16	NMOD	0
20	,	,	O	,	O	16	P	0
21	and	and	O	CC	O	23	NMOD	0
22	elevated	elevate	B-VP	VBN	O	23	NMOD	17	elevated
23	concentrations	concentration	B-NP	NNS	O	11	OBJ	0
24	of	of	B-PP	IN	O	23	NMOD	0
25	lactate	lactate	B-NP	NN	O	24	PMOD	0
26	.	.	O	.	O	3	P	0

1	However	However	B-ADVP	RB	O	15	VMOD	0
2	,	,	O	,	O	15	P	0
3	fetal	fetal	B-NP	JJ	O	4	NMOD	0
4	utilization	utilization	I-NP	NN	O	15	SUB	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	oxygen	oxygen	B-NP	NN	O	8	NMOD	0
7	and	and	I-NP	CC	O	8	NMOD	0
8	glucose	glucose	I-NP	NN	O	5	PMOD	0
9	,	,	O	,	O	4	P	0
10	on	on	B-PP	IN	O	4	NMOD	0
11	a	a	B-NP	DT	O	13	NMOD	0
12	weight	weight	I-NP	NN	O	13	NMOD	0
13	basis	basis	I-NP	NN	O	10	PMOD	0
14	,	,	O	,	O	4	P	0
15	remain	remain	B-VP	VBP	O	0	ROOT	0
16	constant	constant	B-ADJP	JJ	O	15	PRD	0
17	compared	compare	B-PP	VBN	O	15	VMOD	0
18	with	with	B-PP	IN	O	17	PMOD	0
19	control	control	B-NP	NN	O	20	NMOD	0
20	pregnancies	pregnancy	I-NP	NNS	O	18	PMOD	0
21	.	.	O	.	O	15	P	0

1	Maintained	Maintain	B-NP	VBN	O	2	NMOD	0
2	utilization	utilization	I-NP	NN	O	12	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	these	these	B-NP	DT	O	5	NMOD	0
5	substrates	substrate	I-NP	NNS	O	3	PMOD	0
6	,	,	O	,	O	2	P	0
7	in	in	B-PP	IN	O	2	NMOD	0
8	a	a	B-NP	DT	O	10	NMOD	0
9	substrate-deficient	substrate-deficient	I-NP	JJ	O	10	NMOD	0
10	environment	environment	I-NP	NN	O	7	PMOD	0
11	,	,	O	,	O	2	P	0
12	suggests	suggest	B-VP	VBZ	O	0	ROOT	0
13	increased	increase	B-NP	VBN	O	14	NMOD	0
14	sensitivities	sensitivity	I-NP	NNS	O	12	OBJ	0
15	to	to	B-PP	TO	O	14	NMOD	0
16	metabolic	metabolic	B-NP	JJ	O	17	NMOD	0
17	signals	signal	I-NP	NNS	O	15	PMOD	0
18	,	,	O	,	O	17	P	0
19	which	which	B-NP	WDT	O	17	NMOD	0
20	may	may	B-VP	MD	O	19	SBAR	0
21	play	play	I-VP	VB	O	20	VC	0
22	a	a	B-NP	DT	O	23	NMOD	0
23	role	role	I-NP	NN	O	21	OBJ	0
24	in	in	B-PP	IN	O	21	VMOD	0
25	the	the	B-NP	DT	O	26	NMOD	0
26	development	development	I-NP	NN	O	24	PMOD	0
27	of	of	B-PP	IN	O	26	NMOD	0
28	metabolic	metabolic	B-NP	JJ	O	29	NMOD	0
29	diseases	disease	I-NP	NNS	O	27	PMOD	0
30	in	in	B-PP	IN	O	26	NMOD	0
31	later	later	B-NP	JJ	O	33	NMOD	0
32	adult	adult	I-NP	JJ	O	33	NMOD	0
33	life	life	I-NP	NN	O	30	PMOD	0
34	.	.	O	.	O	12	P	0

